DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Kubitza D, Heckmann M, Distler J, Koechel A, Schwers S, Kanefendt F.
Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: a randomized phase 1 multiple-dose study.
Br J Clin Pharmacol 2022;
88 (07) 3447-3462
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.